Question: ibrutinib how does it work?
Answer: The active substance in Imbruvica, ibrutinib, works against cancerous B lymphocytes, a type of white blood cells. It does this by blocking an enzyme called Bruton's tyrosine kinase (Btk), which promotes survival of B lymphocytes and their migration to the organs where these cells normally divide.